September 25, 2020

The Niche

Knoepfler lab stem cell blog

CIRM

2 min read

Back at the beginning of the year I surveyed you readers here on The Niche about the future of CIRM and whether California voters would approve more funding for it in November. That funding effort is now on the ballot as Proposition 14. A month earlier late in 2019 in my yearly 20 predictions for the stem cell and regenerative medicine field I had prognosticated that we California voters would narrowly approve more funding for the California Stem Cell Agency. You can see that …Read More

2 min read

Should California’s Stem Cell Agency, more widely known as CIRM, get another round of funding from us California voters? I believe the answer is yes and I endorse Proposition 14, which would provide the funding for CIRM to translate dozens of clinical trials into some proven new stem cell-based treatments in the coming decade. However, my just saying that as a stem cell scientist doesn’t necessarily have the same resonance as other approaches like a funny new video starring a stem cell who pitches …Read More

4 min read

Why is former Texas Governor/Trump Energy Secretary Rick Perry plugging unproven stem cells from a clinic firm called Celltex for COVID-19 prevention on Fox News? Perry follows in Giuliani’s footsteps? And more generally, what is it with conservative politicians promoting unproven therapies for COVID-19 and in particular stem cells for the novel coronavirus disease? First, we had Rudy Giuliani plugging what he called “stem cells” for COVID-19 on his webcast. This actually turned out to be natural killer (NK) cells, which are not stem …Read More

3 min read

There is always plenty of complicated, mixed-bag news on the stem cell and regenerative medicine front so it’s great to highlight when there’s some good news out there. Today’s post includes several such upbeat items. At the bottom I’ve included a list of some recent interesting publications as well. Good news on vision front: jCyte Therapy Deal with Santen Pharmaceutical. David Jensen over at California Stem Cell Report reported on this blockbuster deal for a quarter of a billion dollars. Jensen wrote: “The California …Read More